Vidyavathi B. Chitharagi, A. Tejashree, Badveti Satyasai, M. Raghavendra and Sheeth Muringeri
Page: 554-558 | Received 01 May 2024, Published online: 02 Jul 2024
Full Text Reference XML File PDF File
Novel corona virus or SARS‐CoV‐2 which lead to the pandemic still emerging with new variants worldwide. The disease may manifest with mild to severe acute respiratory syndrome especially in immunocompromised or in patients with comorbidities. The common symptoms of Covid‐19 include fever, cough, sore throat, breathlessness, fatigue and malaise. Diagnosis of asymptomatic or mild Covid 19 disease is clinically challenging and necessitates laboratory assistance for confirmation. Real time reverse transcriptase polymerase chain reaction (RT‐PCR) is the current gold standard for the molecular diagnosis of SARS‐CoV‐2 infection for the quantitative detection of viral nucleic acid. This retrospective cross‐sectional study was conducted in the department of Microbiology, JSS Hospital, Mysuru, for a period of 3 months from July 2020 to September 2020. During the study period, 200 randomly selected RT‐PCR confirmed COVID‐19 patients admitted to our hospital were followed up for secondary infections, comorbidities and duration of hospital stay. Diabetes mellitus was the most common comorbidity associated with Covid‐19. We also documented the COVID‐19 with coinfection details of the patients. Among 200 patients, 28 patients’ various samples were sent for culture and sensitivity. Among 28 patients who had secondary infections, Candida species was the most common isolate to cause secondary infection, followed by bacterial infections with gram positive and gram‐negative bacteria. Coinfection with viruses, bacteria and fungi among the Covid‐19 patients are serious problems in the COVID‐19 pandemic. Bacterial co‐infections have been a major cause of mortality and concerns for superinfection in COVID‐19 patients. Infection with multi drug resistant bacteria such as Acinetobacter baumannii, Staphylococcus aureus, Klebsiella pneumoniae and Candida species especially in critical care units in COVID‐19 patients may increase the mortality unless treated early in the course.
Vidyavathi B. Chitharagi, A. Tejashree, Badveti Satyasai, M. Raghavendra and Sheeth Muringeri. Secondary Microbial Infections among Covid‐19 Patients and its Effect on Duration of Hospital Stay and Outcome.
DOI: https://doi.org/10.36478/10.36478/makrjms.2024.7.554.558
URL: https://www.makhillpublications.co/view-article/1815-9346/10.36478/makrjms.2024.7.554.558